Healthcare News and Research

Latest Healthcare News and Research

CapsuleTech recognized with 2015 Global Frost & Sullivan Award for Customer Value Leadership

Based on its recent analysis of the medical device integration solutions market, Frost & Sullivan recognizes CapsuleTech with the 2015 Global Frost & Sullivan Award for Customer Value Leadership. CapsuleTech's vendor-agnostic SmartLinx medical device information system (MDIS) has emerged as a valuable data management solution that ties together the medical devices across a healthcare enterprise into a unified system that not only captures and distributes patient clinical data, but also makes available operational data about the devices themselves.

29 May 2015

Guardian Research Network, Molecular Health to provide therapeutic clinical trial access to cancer patients

The Guardian Research Network and Molecular Health have announced a collaboration designed to provide therapeutic clinical trial access and molecular diagnostic decision support to the majority of cancer patients living in U.S. communities.

29 May 2015

FDA approves Humalog 200 units/mL KwikPen to improve glycemic control in diabetic patients

The U.S. Food and Drug Administration (FDA) has approved Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog® (insulin lispro 100 units/mL) to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company announced today. Humalog U-200 KwikPen marks the first FDA approval of a concentrated mealtime insulin analog.

29 May 2015

AAWC educates public on current, evidence-based practices in wound care

Educating the community continues to be a major focus of the Association for the Advancement of Wound Care (AAWC), which was incorporated in 1995.

29 May 2015

Eli Lilly to present Phase III PROCLAIM trial results at ASCO Annual Meeting

Eli Lilly and Company announced final results of the Phase III PROCLAIM trial that will also be discussed in an oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

29 May 2015

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

New clinical data demonstrating the range of treatment options represented in Lilly's diabetes portfolio will be presented in 79 abstracts on June 5-9, at the 75th American Diabetes Association (ADA)® Scientific Sessions in Boston.

29 May 2015

Covalon's revenue increases 24% to $1,742,672 in second quarter 2015

Covalon Technologies Ltd., an advanced medical technologies company, is delighted to announce its financial results for its second quarter ended March 31, 2015, which includes revenue for three months of $2,180,276 and net income for the quarter of $264,340.

29 May 2015

First European approval of drug to treat genetic kidney disease ADPKD

Otsuka Pharmaceutical Co., Ltd. announced that the European Commission has granted marketing authorisation for JINARC® (tolvaptan) for the treatment of ADPKD in adults who have chronic kidney disease (CKD) stage one to three at initiation of treatment with evidence of rapidly progressing disease

29 May 2015

Zimmer finalizes divestiture agreements in furtherance of pending acquisition of Biomet

Zimmer Holdings, Inc. announced today that it has finalized agreements with buyers to divest in the United States certain Zimmer® Unicompartmental High-Flex Knee System assets, Biomet Discovery® Elbow System assets and Cobalt™ bone cement assets.

29 May 2015

Federal funding constraints may jeopardize nation's research enterprise, undermine patient care

Constraints in federal funding, compounded by declining clinical revenue, jeopardize more than the nation's research enterprise.

29 May 2015

DDW 2015: Experts explore efficacy of Stretta therapy for treating chronic GERD patients

A special presentation at Digestive Disease Week 2015 featured GERD experts weighing in on their successful experience using Stretta therapy to treat challenging patient populations suffering from GERD.

29 May 2015

Amgen announces AMG 416 Phase 3 results for treatment of secondary hyperparathyroidism in CKD patients

Amgen today announced pooled data from two pivotal Phase 3, global, randomized, placebo-controlled trials evaluating AMG 416, a novel calcimimetic, for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD) receiving hemodialysis.

29 May 2015

AlloSource's AlloWrap DS amniotic membrane moved to high-cost reimbursement category

AlloSource, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced that AlloWrap DS, its double-sided human amniotic membrane allograft, has been moved to the high-cost reimbursement category.

29 May 2015

Lilly Diabetes Alliance, Boehringer Ingelheim to present study results at ADA’s Scientific Sessions

The presentation of 35 abstracts will demonstrate the breadth and depth of the Boehringer Ingelheim and Eli Lilly and Company Diabetes alliance portfolio at the 75th American Diabetes Association's (ADA) Scientific Sessions® in Boston, June 5-9.

29 May 2015

Amgen creates catalog of qualified tools and reagents to advance basic discoveries in biology

Amgen today announced the creation of a catalog of qualified tools and reagents available to academic institutions to help further research and advance basic discoveries in biology, as well as deepen relationships with academic institutions.

29 May 2015

Healthcare workers serve as vector for MRSA transmission in nursing home settings

Healthcare workers frequently contaminate their gloves and gowns during every day care of nursing homes residents with drug resistant Staphylococcus aureus or MRSA, according to a new study. The findings were published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

29 May 2015

Proteomics research market estimated to reach $1.6 billion this year

Pharmaceutical companies and diagnostics companies spend billions developing new drugs and tests, and this is translating into a sizeable market for the instruments that can assist them. This according to Kalorama Information, a healthcare market research publisher. Kalorama Information said instruments such as mass spectrometry, electrophoresis and liquid chromatography that can assist in the identification of drug targets and the validation of biomarkers, are in demand.

29 May 2015

Robert Rountree honored with Linus Pauling Functional Medicine Award

Robert Rountree, MD, has been honored by receiving the Linus Pauling Functional Medicine Award at the Institute for Functional Medicine's 2015 Annual International Conference, being held May 28-30, 2015 in Austin, Texas. Dr. Rountree receives this award for his pioneering work in the development of Functional Medicine, and for his role as a highly inspirational and informational member of IFM's faculty.

29 May 2015

Tackling comorbidities could improve MS survival

Survival of patients with multiple sclerosis is still reduced, despite recent improvements, say researchers.

28 May 2015

Adult ADHD could be distinct condition

Longitudinal analysis of a birth cohort raises the possibility that attention deficit/hyperactivity disorder in children and in adults may be distinct and unrelated disorders.

28 May 2015

Healthcare News and Research

Latest Healthcare News and Research

CapsuleTech recognized with 2015 Global Frost & Sullivan Award for Customer Value Leadership

Guardian Research Network, Molecular Health to provide therapeutic clinical trial access to cancer patients

FDA approves Humalog 200 units/mL KwikPen to improve glycemic control in diabetic patients

AAWC educates public on current, evidence-based practices in wound care

Eli Lilly to present Phase III PROCLAIM trial results at ASCO Annual Meeting

New clinical data demonstrating treatment options in Lilly's diabetes portfolio to be presented at ADA Scientific Sessions

Covalon's revenue increases 24% to $1,742,672 in second quarter 2015

First European approval of drug to treat genetic kidney disease ADPKD

Zimmer finalizes divestiture agreements in furtherance of pending acquisition of Biomet

Federal funding constraints may jeopardize nation's research enterprise, undermine patient care

DDW 2015: Experts explore efficacy of Stretta therapy for treating chronic GERD patients

Amgen announces AMG 416 Phase 3 results for treatment of secondary hyperparathyroidism in CKD patients

AlloSource's AlloWrap DS amniotic membrane moved to high-cost reimbursement category

Lilly Diabetes Alliance, Boehringer Ingelheim to present study results at ADA’s Scientific Sessions

Amgen creates catalog of qualified tools and reagents to advance basic discoveries in biology

Healthcare workers serve as vector for MRSA transmission in nursing home settings

Proteomics research market estimated to reach $1.6 billion this year

Robert Rountree honored with Linus Pauling Functional Medicine Award

Tackling comorbidities could improve MS survival

Adult ADHD could be distinct condition

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in